Fang Z. Shi

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Continuation of first-line therapy with radiotherapy for oligoprogression versus early switch to second-line therapy in oligoprogressive hepatocellular carcinoma (CROSS): study protocol of a multicentre, randomised, controlled, open-label, phase III trial.

Continuation of first-line therapy with radiotherapy for oligoprogression versus early switch to second-line therapy in oligoprogressive hepatocellular carcinoma (CROSS): study protocol of a multicentre, randomised, controlled, open-label, phase III trial.

Journal: BMJ open

Published: June 09, 2026

High-strength conductive PVA/lignosulfonate/tannic acid/Cu2+ hydrogel for multifunctional wound dressing.

High-strength conductive PVA/lignosulfonate/tannic acid/Cu2+ hydrogel for multifunctional wound dressing.

Journal: International journal of biological macromolecules

Published: May 09, 2026

Multi-level design of a chitosan-based membrane: from sisal fiber reinforcement to surface micropatterning and hybrid hap for enhanced bone regeneration.

Multi-level design of a chitosan-based membrane: from sisal fiber reinforcement to surface micropatterning and hybrid hap for enhanced bone regeneration.

Journal: Carbohydrate polymers

Published: February 16, 2026

Bevacizumab plus iparomlimab/tuvonralimab with hepatic artery infusion chemotherapy followed by stereotactic body radiotherapy in patients with BCLC stage C hepatocellular carcinoma with thrombus and/or extrahepatic oligometastases (BITS-TO-HCC): study protocol of a prospective, single-center, single-arm, phase II study.

Bevacizumab plus iparomlimab/tuvonralimab with hepatic artery infusion chemotherapy followed by stereotactic body radiotherapy in patients with BCLC stage C hepatocellular carcinoma with thrombus and/or extrahepatic oligometastases (BITS-TO-HCC): study protocol of a prospective, single-center, single-arm, phase II study.

Journal: Therapeutic advances in medical oncology

Published: November 26, 2025

Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Trial.

Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 24, 2025

Cell-free DNA methylation-based detection of organ damage following proton versus photon radiotherapy: a case series.

Cell-free DNA methylation-based detection of organ damage following proton versus photon radiotherapy: a case series.

Journal: Translational pediatrics

Published: October 14, 2025

Efficacy and safety evaluation of radiotherapy approach based on spatially fractionated radiotherapy and stereotactic core ablative radiation therapy technologies for bone metastatic malignant tumors with soft tissue formation: A randomized controlled phase II trial.

Efficacy and safety evaluation of radiotherapy approach based on spatially fractionated radiotherapy and stereotactic core ablative radiation therapy technologies for bone metastatic malignant tumors with soft tissue formation: A randomized controlled phase II trial.

Journal: Precision radiation oncology

Published: July 06, 2025

Sintilimab plus fruquintinib with or without radiotherapy for third-line treatment of colorectal cancer with liver metastases: study protocol for a randomized controlled, multicenter phase II trial.

Sintilimab plus fruquintinib with or without radiotherapy for third-line treatment of colorectal cancer with liver metastases: study protocol for a randomized controlled, multicenter phase II trial.

Journal: Frontiers in immunology

Published: May 04, 2025

Imaging biomarkers related to tumor-associated macrophage in immunotherapy treatment planning for non-small cell lung cancer.

Imaging biomarkers related to tumor-associated macrophage in immunotherapy treatment planning for non-small cell lung cancer.

Journal: Translational lung cancer research

Published: March 18, 2025

Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial.

Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial.

Journal: EClinicalMedicine

Published: March 05, 2025

Study protocol for a single-arm phase Ib/II trial of Ivonescimab combined with adapted guided stereotactic body radiotherapy and chemotherapy in patients with locally advanced pancreatic cancer.

Study protocol for a single-arm phase Ib/II trial of Ivonescimab combined with adapted guided stereotactic body radiotherapy and chemotherapy in patients with locally advanced pancreatic cancer.

Journal: BMC cancer

Published: February 28, 2025

Efficacy and safety of radiotherapy to delay second-line systemic therapy in patients with oligoprogressive hepatocellular carcinoma: study protocol of a multicentre, single-arm, phase II trial.

Efficacy and safety of radiotherapy to delay second-line systemic therapy in patients with oligoprogressive hepatocellular carcinoma: study protocol of a multicentre, single-arm, phase II trial.

Journal: Therapeutic advances in medical oncology

Published: January 07, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026